NIAID-VRC- Rapid Manufacturing Response

疫苗研究中心（VRC）的使命和范围包括将临床候选药物从研究台中快速转移到开发和GMP生产到临床。VRC正在探索一系列广泛的举措，包括但不限于缩短候选药物发现和首次人体临床试验之间时间的新技术。这些举措将使VRC和NIAID能够迅速评估临床阶段产品的安全性和有效性，并在突发公共卫生事件期间加快生产和向现场供应试验性产品。

The Vaccine Research Center (VRC) mission and scope includes rapidly moving clinical candidates from the research bench through development and GMP manufacturing to the clinic. The VRC is exploring a wide range of initiatives, including but not limited to new technologies which would decrease the time between candidate discovery and first-in-human clinical trials. These initiatives will allow VRC and NIAID to quickly assess clinical stage products for safety and efficacy and to expedite the production and supply of investigational products to the field during public health emergencies.